16:19 EST Sonnet BioTherapeutics (SONN) files to sell 2M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on SONN: Sonnet BioTherapeutics Expands Phase 1 Study for SON-1010 Sonnet BioTherapeutics expands Phase 1 SB101 trial Sonnet BioTherapeutics reports FY24 EPS ($11.35) vs. ($145.13) last year Sonnet BioTherapeutics sees cash runway into July 2025 SONN Earnings this Week: How Will it Perform? Disclaimer & DisclosureReport an Issue
